|
HS Code |
935377 |
| Product Name | 6-Bromo-2-Chloro-3-Methylphenylboronic Acid |
| Cas Number | 1243893-09-9 |
| Molecular Formula | C7H7BBrClO2 |
| Molecular Weight | 261.30 g/mol |
| Appearance | White to off-white solid |
| Purity | Typically ≥98% |
| Chemical Class | Arylboronic acid |
| Synonyms | 2-Chloro-6-bromo-3-methylphenylboronic acid |
| Storage Conditions | Store at 2-8°C, protected from moisture |
| Solubility | Soluble in DMSO, methanol, and ethanol |
| Smiles | CC1=C(C(=CC(=C1)Br)B(O)O)Cl |
| Application | Suzuki-Miyaura cross-coupling reactions |
As an accredited 6-Bromo-2-Chloro-3-Methylphenylboronic Acid factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.
| Packing | |
| Shipping | |
| Storage |
Competitive 6-Bromo-2-Chloro-3-Methylphenylboronic Acid prices that fit your budget—flexible terms and customized quotes for every order.
For samples, pricing, or more information, please call us at +8615371019725 or mail to admin@sinochem-nanjing.com.
We will respond to you as soon as possible.
Tel: +8615371019725
Email: admin@sinochem-nanjing.com
Flexible payment, competitive price, premium service - Inquire now!
In the field of organic synthesis, chemists are always chasing reliability and precision. I've seen a lot of attempts to reach the next big breakthrough, but substantial progress often comes down to choosing the right building blocks. 6-Bromo-2-Chloro-3-Methylphenylboronic Acid has been playing a bigger role than many outsiders realize. It stands out because of its structure—boronic acid on an aromatic ring spiced up with bromo, chloro, and methyl functional groups. This design isn’t just a series of dots and dashes on a chemist’s sketchpad—it affects how reactions play out in real labs and research settings. Being able to influence reactivity and compatibility with other reagents makes this compound more than a simple component; it pushes projects forward where lesser reagents hit dead ends.
I remember working through countless reaction lists at the bench, often running Suzuki-Miyaura cross-couplings. It doesn’t take long to realize that the quality of a boronic acid determines how much troubleshooting we end up doing. In the case of 6-Bromo-2-Chloro-3-Methylphenylboronic Acid, placing a boronic acid onto a phenyl ring already sets up a versatile group for key reactions. The extra punch comes from the bromine and chlorine atoms, which dial in electronic effects and change the reactivity of the core. That methyl group sometimes gets overlooked, but it helps drive selectivity and reduces competing side-reactions. These factors mean that, while there is no “simple” chemistry, working with this compound takes some of the guesswork—and the wasted weeks—out of challenging cross-coupling protocols, especially for users seeking high yields and cleaner product pools.
My hands have known the stick of glassware rinsed in all sorts of arylboronic acids, and the difference between a sluggish reaction and a productive one often shows up at scale. 6-Bromo-2-Chloro-3-Methylphenylboronic Acid slots in well where many molecules stumble. In actual labs, its boronic acid group partners gracefully with palladium catalysts, giving users a sturdy platform for coupling with a wide range of aryl halides and vinyl systems. That bromo and chloro substitution pattern means you don’t need constant tweaks to your catalyst or temperature profiles—average users see better-than-usual conversion rates straight out of standard protocols. Synthesis projects—especially in medicinal chemistry—count on this kind of reliability. When chasing a potent kinase inhibitor, the difference between minutes and months in an experimental cycle starts here, with consistent intermediates that don’t foul up columns or require endless purification.
The modern pharmaceutical world keeps moving toward complexity—more heterocycles, more substitutions, tighter structure-activity relationships. What I’ve seen is that 6-Bromo-2-Chloro-3-Methylphenylboronic Acid carves out its value by enabling sophisticated scaffold assembly. It lets chemists build up molecules with deliberate precision. I’ve talked with teams who used this compound to assemble lead candidates not accessible through off-the-shelf phenylboronic acids. That careful balance between reactivity and stability makes the difference. You see real progress in small-molecule drug discovery programs and advances in organic electronics, where aromatic substitution patterns affect conductivity and charge transport. Researchers benefit from a material that doesn’t just open doors on paper but does so in real-world flask and scale-up environments.
There’s an ocean of arylboronic acids on the chemist’s shelf—some with fewer substitutions, some more crowded with groups. Picking one is about more than matching a model number or spec sheet. In results I’ve seen, 6-Bromo-2-Chloro-3-Methylphenylboronic Acid keeps its solubility under control across a range of common solvents. That kind of predictability is rare. Other boronic acids with just a single substituent—say, straight 4-methyl or 4-bromo—sometimes bring headaches with purification or side reactions that chew through valuable starting materials. This compound’s structure holds onto integrity even as conditions change, and it tolerates the trial and error that day-to-day lab work brings. That’s worth more than a fancy catalogue entry.
Chemists who have worked with low-grade or poorly characterized chemicals learn fast that a few points of impurity spell disaster for downstream work. 6-Bromo-2-Chloro-3-Methylphenylboronic Acid, provided it meets clear analytical criteria—clean NMR signatures, tight HPLC purity, and verified melting points—takes a chunk of the risk out of process design. In the field, users report that lots supplied to pharmaceutical and R&D specifications pass these checks without residue or non-specific byproducts. This transparency lets teams move forward with confidence; you spend resources actually testing new ideas, not cleaning up after cheap starting points. It’s also about minimizing project delays; surprises late in the game cost more than up-front investments in better quality.
The broader scientific literature keeps stacking up. Publications and patent filings show a steady demand for 6-Bromo-2-Chloro-3-Methylphenylboronic Acid in routes to advanced pharmaceutical targets and functionalized organic materials. I’ve seen journal records highlighting improved pharmacological properties and lower toxicity profiles tied to final molecules built using this intermediate. Research groups look at this kind of boronic acid when flexibility and synthetic reach matter most. It has contributed to cancer therapy explorations, next-generation OLED materials, and new agrochemical agents. This isn’t hype; it’s about working with evidence and actual outcomes, not marketing claims.
I remember one project that started with a standard 4-chlorophenylboronic acid. We chased impurities for weeks, never hitting clean endpoints. As soon as the 6-Bromo-2-Chloro-3-Methylphenylboronic Acid was introduced, the difference was clear—better site selectivity, fewer byproducts even under less forgiving coupling conditions, and a product that finished columns smoothly. The combination of bromine and chlorine not only increases reactivity at the intended position, it blocks off dead-end pathways that drag out synthesis. Methyl substitution, often overlooked by those chasing bigger molecular changes, tunes both electron flow and steric access, which makes the overall reaction profile more predictable. Switching to this compound in key steps has led to big savings on both materials and time.
The demands of industry go deeper than simple R&D, especially when scaling up to pilot or production levels. Chemists talk about “scalability,” but that word only means something if the material stands up to bigger batch sizes, new reactors, and more complicated logistics. This boronic acid’s stability under ambient conditions and resistance to rapid degradation mean it survives outside perfect glovebox conditions and offers a shelf life that supports ongoing manufacturing. In discussions with operations teams, the key challenge is usually about keeping process consistency through scale-up. 6-Bromo-2-Chloro-3-Methylphenylboronic Acid’s performance stands up to those tests—whether it sits in a small R&D fridge or comes out of a warehouse on the way to a kilo-scale campaign, the results match. Not every available boronic acid can say that; minor candidates drop out as conditions get harsher.
On a personal note, I’ve watched junior researchers become stuck with stubborn intermediates that just wouldn’t finish reactions the way project leads expected. Every improvement in a core building block, even something as humble as a boronic acid, changes prospects for a whole team. With 6-Bromo-2-Chloro-3-Methylphenylboronic Acid, I saw students finally pull off key couplings—no more days spent troubleshooting a leaking spot on TLC, and no more guessing which interaction was corrupting a run. That confidence spreads. Experienced chemists start proposing bolder targets, knowing that their foundation holds up across new methods or catalyst systems. Real progress comes from results, not from catalog speculation, and this compound stands behind those results time and again.
There’s growing momentum behind sustainable chemistry, and it touches every decision. My experience tells me that even boutique reagents have environmental footprints, yet 6-Bromo-2-Chloro-3-Methylphenylboronic Acid can be sourced at purity levels that reduce waste in final purification. Smaller solvent volumes, less reliance on harsh acids or bases, and easier recovery of the product mean less hauling of drums to disposal and lower costs for waste management. The scientific community now expects transparency about where raw materials come from and how cleanly they behave. Feedback from corporate social responsibility teams and academic partners has stressed sourcing qualities in line with evolving guidelines, such as REACH initiatives and responsible supplier agreements. Chemistry needs to serve a larger purpose; this compound merits a closer look on those grounds.
Working in any synthetic lab teaches practical tricks, both from experienced mentors and from each tough day at the bench. In my experience, 6-Bromo-2-Chloro-3-Methylphenylboronic Acid doesn’t demand finicky protocols—researchers often store it in standard dry environments and draw samples without elaborate protection from air or moisture. Routine checking by thin-layer chromatography or NMR confirms its stability, which reassures anyone dealing with time crunches between reaction setups. Accurate weighing, straightforward dissolution in customary polar aprotic solvents, and reliable filtration standards all help. Users seem to get more runs done with fewer setbacks, which counts for a lot during testing campaigns.
The market for functionalized boronic acids is busy, and a powerful intermediate like this will keep gaining ground. Pharmacy pipelines and high-performance material producers push for complex aromatic systems that stretch ordinary chemistry. I’ve seen numerous requests for batches of 6-Bromo-2-Chloro-3-Methylphenylboronic Acid as drug candidates move through clinical validation, where small changes in a synthetic intermediate ripple through stability, efficacy, and patient outcomes. On the electronics side, product designers invest in advanced organic semiconductors; subtle changes at a molecular level shape device performance. This compound fits the demands of modern science, adapting to new synthetic methodologies, such as flow chemistry and tandem couplings, that require robustness and predictable yields.
No chemical is a silver bullet, and every research team runs into hurdles—batch variability, scale-up losses, or regulatory headaches. A big step forward can come from up-front investment in better QA/QC, involving third-party verification for each shipment and tracing provenance through the full supply chain. Wider adoption of 6-Bromo-2-Chloro-3-Methylphenylboronic Acid relies on integrating real user feedback—what worked, what went sideways—back into the production process. Supply partners who share the data, allow sample access before major orders, and collaborate with customers on evolving targets keep chemistry moving forward instead of bottlenecking it. Academic and industrial groups benefit by sharing these lessons and contributing to best practices on both handling and application, so each cycle brings fewer unknowns.
In all these discussions, safety comes up. It becomes second nature in a setting where even mild boronic acids can irritate skin or eyes. Good habits—right gloves, protective goggles, and careful fume hood work—carry over from handling more aggressive halogenated compounds. Teams report no major hazards unique to this boronic acid when following standard organometallic protocols. Training for new researchers makes a bigger difference than further tweaking the product itself. Reliable labeling, documented procedures, and clear hazard communication give everyone peace of mind, especially in busier group settings. It all comes back to making space for creative science without running unnecessary risks.
Years in laboratory science have shown that the best outcomes grow from relentless attention to detail, including the small choices behind each reaction, and 6-Bromo-2-Chloro-3-Methylphenylboronic Acid proves that principle. Its carefully designed structure, stable handling properties, and proven performance across multiple application areas make it more than just another reagent. Whether advancing pharmaceutical research, improving next-generation electronics, or supporting industrial-scale synthesis, this compound illustrates what’s possible when practical needs and innovative chemistry align. Putting in the time to select and work with the right intermediate pays off with shorter project times, stronger data, and more meaningful discoveries. That’s a lesson every chemist learns sooner or later, often at the cost of wasted resources before finding the right solution.